Infectious Disease Therapeutics Market By Drug class (Anti-Bacterial, Anti-Viral, Anti-Parasite, Anti-Fungal, Others), by disease indication (HIV/AIDS, Influenza, Hepatitis, Malaria, TB, Others), by Distribution channel (Hospital Pharmacy, Retail Pharmacy, Others), and Geography

 

Purchase Option

$ 3000
$ 4400
$ 6600
$ 8900

Infectious Disease Therapeutics Market size valued USD 121.4 billion in 2021 and expected to reach USD 166.32 billion by 2028, at a CAGR of 4.6% during the forecast period 2022-2028. Infectious diseases are caused by organisms, such as bacteria, virus, fungi or parasites. Many organisms live in our body but few of them cause diseases. These infectious diseases are transmitted from one individual to other either by direct or indirect contact. The drugs used for infectious diseases are antibiotics, antiviral, and antiparasitic, among others. Infectious disease therapeutics acts directly on organisms or helps the body system to fight infections. Infectious diseases include HIV, malaria, tuberculosis, hepatitis, and influenza, among others. Market players focus on mergers, acquisitions and collaborations to increase revenue share in the market. For instance, in August 2016, Pfizer acquired AstraZeneca’s late-stage small molecule anti-infectives business for development and commercialization outside the U.S. In addition, market players investing on research and development to introduce new drugs and to strengthen their position in the infectious disease therapeutics market. Some of the pipeline anti-infectives include avycaz (ceftazidime and avibactam), bictegravir (Anti HIV), cabotegravir (Anti HIV). Patent expiry of blockbuster anti-infectives such as Tamiflu, cubicin and ambisome are expected to negatively effect the infectious disease therapeutics market. Key Developments: In July 2017, Gilead’s “vosevi” oral tablet was approved by U.S. FDA for treatment of adults with chronic hepatitis C virus In March 2015, U.S. Food and Drug Administration approved cresemba (isavuconazonium sulfate), a novel antifungal drug for treat adults with invasive aspergillosis and invasive mucormycosis, rare but serious infections In December 2014, Sanofi Pasteur announces FDA approval of fluzone intradermal quadrivalent (Influenza Vaccine) for adults.

Global Infectious Disease Therapeutics Market Summary

Study Period

2023-29

Base Year

2022

CAGR

4.6%

Largest Market

North America

Fastest Growing Market

Asia-Pacific
Infectious Disease Therapeutics Market Dynamics

Infectious disease therapeutics market is driven by the growing prevalence rates of infectious diseases, increased healthcare expenditure and increased funding of governments on prevention and management of infectious diseases. In addition, increased geriatric population and use of direct acting antiviral drugs are fuelling the growth of infectious diseases therapeutics market. However, patent expiry of many infectious disease drugs and increase number of generic alternatives hindering the market revenue of infectious disease therapeutics market.

Key Features of the Reports

  • The report provides granular level information about the market size, regional market share, historic market (2018 to 2022) and forecast (2023 to 2029)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup’s details that are actively working in the market
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
  • The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market

Global Infectious Disease Therapeutics Market Segmentation

Based on drug class
  • Anti-Bacterial
  • Anti-Viral
  • Anti-Parasite
  • Anti-Fungal
  • Others
Disease Indication
  • HIV/AIDS
  • Influenza
  • Hepatitis
  • Malaria
  • TB
  • Others
Distribution Channel
  • Hospital Pharmacy
  • Retail Pharmacy
  • Others

Frequently Asked Questions

2021 is the base year and 2028 is the forecast year.

The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).

In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.

  1. Executive summary
  2. Global Infectious Disease Therapeutics Market Introduction
    • Global Infectious Disease Therapeutics Market– Taxonomy
    • Global Infectious Disease Therapeutics Market– Definitions
      • Drug Class
      • Disease Indication
  1. Global Infectious Disease Therapeutics Market Dynamics
    • Drivers
    • Restraints
    • Opportunities/Unmet Needs of the Market
    • Trends
    • Global Infectious Disease Therapeutics Market Dynamics – Factors Impact Analysis
    • Global Infectious Disease Therapeutics Market– Regulations
      • US
      • Europe
      • Japan
  1. Global Infectious Disease Therapeutics Market Analysis, 2015 - 2019 and Forecast, 2020 – 2026
    • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
    • Year-over-Year (Y-o-Y) Growth Analysis (%)
    • Market Oppurtunity Analysis
  2. Global Infectious Disease Therapeutics Market, By Drug Class, 2015 - 2019 and Forecast, 2020 - 2026
    • Anti-Bacterial
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Anti-Viral
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Anti-Parasite
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Anti-Fungal
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Others
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
  1. Global Infectious Disease Therapeutics Market Forecast, By Disease Indication, 2015 - 2019 and Forecast, 2020 - 2026
    • HIV/AIDS
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Influenza
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Hepatitis
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Malaria
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Tuberculosis (TB)
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Others
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
  1. Global Infectious Disease Therapeutics Market Forecast, By Distribution Channel, 2015 - 2019 and Forecast, 2020 - 2026
    • Hospital Pharmacies
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Retail Pharmacies
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Online Pharmacies
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
  1. Global Infectious Disease Therapeutics Market Forecast, By Region, 2015 - 2019 and Forecast, 2020 - 2026
    • North America
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Europe
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Asia-Pacific
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Latin America
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Middle East and Africa
      • Market Analysis, 2015 – 2019 and Forecast, 2020 – 2026 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Global Infectious Disease Therapeutics Market- Opportunity Analysis Index - By Drug Class, By Disease Indication, By Distribution Channel, and Region, 2020 – 2026
  2. North America Infectious Disease Therapeutics Market Analysis, 2015 - 2019 and Forecast, 2020 - 2026
    • Drug Class Analysis (2015 – 2019) and Forecast (2020 – 2026) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
      • Anti-Bacterial
      • Anti-Viral
      • Anti-Parasite
      • Anti-Fungal
      • Others
    • Disease Indication Analysis (2015 – 2019) and Forecast (2020 – 2026) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • HIV/AIDS
      • Influenza
      • Hepatitis
      • Malaria
      • TB
      • Others
    • Distribution Channel Analysis (2015 – 2019) and Forecast (2020 – 2026) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
    • Country Analysis (2015 – 2019) and Forecast (2020 – 2026) by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • S.
      • Canada
    • North America Infectious Disease Therapeutics Market- Opportunity Analysis Index - By Drug Class, By Disease Indication, By Distribution Channel, and Country, 2020 – 2026
    • North America Infectious Disease Therapeutics Market Dynamics – Trends
  3. Europe Infectious Disease Therapeutics Market Analysis, 2015 - 2019 and Forecast, 2020 - 2026
    • Drug Class Analysis (2015 – 2019) and Forecast (2020 – 2026) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
      • Anti-Bacterial
      • Anti-Viral
      • Anti-Parasite
      • Anti-Fungal
      • Others
    • Disease Indication Analysis (2015 – 2019) and Forecast (2020 – 2026) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • HIV/AIDS
      • Influenza
      • Hepatitis
      • Malaria
      • TB
      • Others
    • Distribution Channel Analysis (2015 – 2019) and Forecast (2020 – 2026) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
    • Country Analysis (2015 – 2019) and Forecast (2020 – 2026) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Germany
      • UK
      • France
      • Spain
      • Italy
      • Russia
      • Poland
      • Rest of Europe
    • Europe Infectious Disease Therapeutics Market- Opportunity Analysis Index - By Drug Class, By Disease Indication, By Distribution Channel, and Country, 2020 – 2026
    • Europe Infectious Disease Therapeutics Market Dynamics – Trends
  4. Asia-Pacific Infectious Disease Therapeutics Market Analysis, 2015 - 2019 and Forecast, 2020 - 2026
    • Drug Class Analysis (2015 – 2019) and Forecast (2020 – 2026) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
      • Anti-Bacterial
      • Anti-Viral
      • Anti-Parasite
      • Anti-Fungal
      • Others
    • Disease Indication Analysis (2015 – 2019) and Forecast (2020 – 2026) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • HIV/AIDS
      • Influenza
      • Hepatitis
      • Malaria
      • TB
      • Others
    • Distribution Channel Analysis (2015 – 2019) and Forecast (2020 – 2026) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
    • Country Analysis (2015 – 2019) and Forecast (2020 – 2026) by Revenue (USD Mn),
  5. Y-o-Y Growth (%), and Market Share (%)
    • Japan
    • China
    • India
    • ASEAN
    • Australia & New Zealand
    • Rest of Asia-Pacific
  • Asia-Pacific Infectious Disease Therapeutics Market- Opportunity Analysis Index - By Drug Class, By Disease Indication, By Distribution Channel, and Country, 2020 – 2026
  • Asia-Pacific Infectious Disease Therapeutics Market Dynamics – Trends
  1. Latin America Infectious Disease Therapeutics Market Analysis, 2015 - 2019 and Forecast, 2020 - 2026
    • Drug Class Analysis (2015 – 2019) and Forecast (2020 – 2026) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
      • Anti-Bacterial
      • Anti-Viral
      • Anti-Parasite
      • Anti-Fungal
      • Others
    • Disease Indication Analysis (2015 – 2019) and Forecast (2020 – 2026) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • HIV/AIDS
      • Influenza
      • Hepatitis
      • Malaria
      • TB
      • Others
    • Distribution Channel Analysis (2015 – 2019) and Forecast (2020 – 2026) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
    • Country Analysis (2015 – 2019) and Forecast (2020 – 2026) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Brazil
      • Mexico
      • Argentina
      • Venezuela
      • Rest of Latin America
    • Latin America Infectious Disease Therapeutics Market- Opportunity Analysis Index - By Drug Class, By Disease Indication, By Distribution Channel, and Country, 2020 – 2026
    • Latin America Infectious Disease Therapeutics Market Dynamics – Trends
  2. Middle East & Africa Infectious Disease Therapeutics Market Analysis, 2015 - 2019 and Forecast, 2020 - 2026
    • Drug Class Analysis (2015 – 2019) and Forecast (2020 – 2026) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
      • Anti-Bacterial
      • Anti-Viral
      • Anti-Parasite
      • Anti-Fungal
      • Others
    • Disease Indication Analysis (2015 – 2019) and Forecast (2020 – 2026) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • HIV/AIDS
      • Influenza
      • Hepatitis
      • Malaria
      • TB
      • Others
    • Distribution Channel Analysis (2015 – 2019) and Forecast (2020 – 2026) by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online Pharmacies
    • Country Analysis (2015 – 2019) and Forecast (2020 – 2026) by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
      • Gulf Cooperation Council (GCC) Countries
      • Israel
      • South Africa
      • Rest of MEA
    • MEA Infectious Disease Therapeutics Market- Opportunity Analysis Index - By Drug Class, By Disease Indication, By Distribution Channel, and Country, 2020 – 2026
    • MEA Infectious Disease Therapeutics Market Dynamics – Trends
  3. Competition Landscape
    • Strategic Dashboard of Top Market Players
    • Company Profiles (Introduction, Financial Analysis, Drug & Service Offerings, Key Developments, Strategies, and SWOT Analysis)
      • GlaxoSmithKline Plc (U.K.)
      • Johnson & Johnson Services, Inc. (U.S.)
      • Merck & Co, Inc. (U.S.)
      • Pfizer Inc. (U.S.)
      • Novartis AG. (Switzerland)
      • AbbVie Inc. (U.S.)
      • Astellas Pharma Inc. (Japan)
      • AstraZeneca (U.K.)
      • Auritec Pharmaceuticals Inc. (U.S.)
      • Bayer AG (Germany)
      • Chimerix Inc. (U.S.)
  4. Research Methodology
  5. Key Assumptions and Acronyms

  • GlaxoSmithKline Plc (U.K.)
  • Johnson & Johnson Services, Inc. (U.S.)
  • Merck & Co, Inc. (U.S.)
  • Pfizer Inc. (U.S.)
  • Novartis AG. (Switzerland)
  • AbbVie Inc. (U.S.)
  • Astellas Pharma Inc. (Japan)
  • AstraZeneca (U.K.)
  • Auritec Pharmaceuticals Inc. (U.S.)
  • Bayer AG (Germany)
  • Modified Polymer Components, Inc. (Bristol-Myers Squibb) (U.S.)
  • Chimerix Inc. (U.S.)
  • Eli Lilly and Company (U.S.)
  • Isis Pharmaceuticals (U.S.)
  • Mitsubishi Chemical Holdings Corporation (Mitsubishi Tanabe Pharma) (Japan)
  • Sanofi S.A. (France)
  • Gilead Sciences (U.S.)